Pharmegic – R&D Services
Formulation innovation. Regulatory alignment. Partner-ready execution.
Overview
Whether you’re a virtual biotech or a mid-sized sponsor seeking expert formulation support, Pharmegic delivers science-first, lean, and globally aligned R&D solutions.
Our R&D Capabilities
Complex Injectables: Depot, RTU, nanosuspensions, emulsions - Oral Solids: IR/ER tablets, MUPS, multilayered tablets, pellets - Oral Liquids: Solutions, suspensions, pediatric formulations - Sterile Ophthalmics: Aqueous and suspension formulations
Fee-for-Service Model
Precision R&D. On your terms.
We operate as an external R&D engine for clients who need reliable, high-quality development services without the cost of internal infrastructure. Our team supports programs from pre-formulation through exhibit batch and tech transfer.
Services Include: - Pre-formulation and formulation development - Analytical method development and validation - ICH stability studies - Exhibit batch and scale-up support - Regulatory-aligned documentation for tech transfer
All projects are milestone-driven, with clear timelines and transparent costing.
Co-Development Model
Shared risk. Shared innovation.
For select opportunities, Pharmegic engages in co-development partnerships — ideal for differentiated formulations, 505(b)(2) strategies, or repurposed assets.
We provide full R&D execution while jointly structuring ownership or commercial rights. This model works best for: - Shelf-ready but underutilized compounds - Lifecycle extension opportunities - Regional or niche market products
Each co-development opportunity is assessed on strategic fit, scientific feasibility, and market potential.